Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis
Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis
Recruiting · NCT06684522 · Registry updated 2026-05-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis | Eyelid Dermatitis | Recruiting | Early phase 1 | 2026-05-26 | NCT06684522 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Northwestern University | 381 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northwestern University Department of Dermatology | Chicago | United States | 14 |